| Homer L Cox, CRNA | |
|
1407 Whisenant Dr, Duncan, OK 73533 | |
| (580) 251-8847 | |
| (580) 251-8869 |
| Full Name | Homer L Cox |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 1407 Whisenant Dr, Duncan, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407817075 | NPI | - | NPPES |
| 731219345002 | Other | OK | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R0029072 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Homer L Cox, CRNA 1111 W Willow Ave, Ste 106, Duncan, OK 73533 Ph: (580) 252-6366 | Homer L Cox, CRNA 1407 Whisenant Dr, Duncan, OK 73533 Ph: (580) 251-8847 |
News Archive
Isis Pharmaceuticals, Inc. announced today that it has earned a $5 million milestone payment from GlaxoSmithKline related to the designation of ISIS-GSK4Rx as a development candidate. ISIS-GSK4Rx is an antisense drug designed to treat an undisclosed ocular disease.
Described in an advance, online publication of the journal Nature Biotechnology on February 22, 2009, the team's general method could be adapted for detecting a wide variety of compounds, including many that are relevant to diagnostic medicine and environmental work.
With 75% of cancer patients in the UK over 60, and the costs of innovative drugs soaring, how to best identify and hopefully manage cancer-related pain in the elderly is a key issue. A new study published in the Journal of Gender Studies looks into this complex matter and, in claiming gender and personality significantly affect the experience of suffering, questions a 'one size fits it all' approach to pain management.
In response to adverse event reports received by ECRI Institute PSO and to promote such learning, ECRI Institute PSO has begun disseminating periodic Patient Safety E-lerts to participating organizations. The Patient Safety E-lert will bring attention to these issues and is concisely formatted to stimulate discussion and action by interdisciplinary committees focused on reducing the risk of healthcare events.
Neuland Laboratories Ltd., a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and custom manufacturing solutions services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2015, ended December 31, 2014.
› Verified 6 days ago
Matthew W Roberson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 | |
Janice K Palovik, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 | |
Mr. Jeffrey L Hopkins, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1308 Highiand Way, Duncan, OK 73533 Phone: 580-467-7185 | |
Andrew P Flesher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 | |
Steven M Hallford, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1407 Whisenant Dr, Duncan, OK 73533 Phone: 580-251-8847 Fax: 580-251-8869 |